WuXi Invests In Genomics Data Firm | Chemical & Engineering News
Volume 93 Issue 17 | p. 15 | Concentrates
Issue Date: April 27, 2015

WuXi Invests In Genomics Data Firm

Department: Business
Keywords: gene sequencing, contract research

WuXi PharmaTech, a Shanghai-based pharmaceutical services firm, has invested $15 million in DNAnexus, which calls itself the leader in cloud-based genome data management. Along with the investment, genome-sequencing services offered by WuXi’s NextCode business will become available via DNAnexus’s cloud computing service. WuXi acquired NextCode earlier this year. DNAnexus CEO Richard Daly notes that China is home to 20% of the world’s DNA-sequencing capacity.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment